Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
SeraCare™ ToRCH Performance Panels
Click to view available options
Quantity:
25 x 0.5 mL
Description
Panel of undiluted serum and plasma samples with anti-Herpes Simplex Virus reactivity ranging from negative to strongly positive; samples were selected to demonstrate IgG and/or IgM reactivity
- Negative plasma and sera are included as nonreactive controls
- Extensive array of panels helps labs maintain the highest standards for assay validation, regulatory compliance and method development
- Each panel includes comprehensive, comparative data from a variety of methods and commercially available test kits, allowing reagent assay/platform performance, sensitivity and specificity to be independently challenged
- Assembled from highly characterized, disease state patient samples, and developed specifically for infectious disease testing
- Enables labs to evaluate, monitor and troubleshoot test and staff performance
- Minimizes down time and accelerates validation and verification of new test methods, reagent systems and platforms
- Rigorously tested and characterized using highest-quality test methods
- Comprehensive test results provided with each panel; quantified against international standards when available
- Long-term stability and availability
- SeraCare facilities are ISO 9001 and 13485 certified and comply with cGMP standards
Specifications
Specifications
Certifications/Compliance | ISO 9000 13485 |
Type | ToRCH Anti-HSV Type 1 and 2 Mixed Titer Performance Panel |
Includes | Undiluted Serum and Plasma samples with anti-Herpes Simplex Virus reactivity ranging from negative to strongly positive |
Intended Use | Evaluating of Anti-Herpes simplex tests |
Matrix | Serum and Plasma |
Quantity | 25 x 0.5 mL |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction